Defiance ETFs today announced the launch of the Defiance Autism Impact ETF (Ticker: ASD), the first exchange-traded fund designed to provide targeted exposure to publicly traded companies developing products, therapies, services, technologies, and innovations supporting individuals with autism and related neurodevelopmental conditions.
Defiance ETFs today announced the launch of the Defiance Autism Impact ETF (Ticker: ASD), the first exchange-traded fund designed to provide targeted exposure to publicly traded companies developing products, therapies, services, technologies, and innovations supporting individuals with autism and related neurodevelopmental conditions.